Dr. Leider most recently served as chief medical officer of Gelesis, a biotechnology company that developed a medical device to treat obesity. He also was the chief medical officer of Walgreens, where he focused on clinical program development and global executive leadership.
In his role at AposHealth, Dr. Leider will oversee the company’s payer and engagement services. He will also serve on the company’s senior leadership team and focus on provider network development and medical affairs functions, according to a Jan. 17 release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
